<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01362283</url>
  </required_header>
  <id_info>
    <org_study_id>114619</org_study_id>
    <nct_id>NCT01362283</nct_id>
  </id_info>
  <brief_title>Epidemiologic Study to Evaluate the Proportion of Cardiovascular Disease Risk Factors in Korean Hypertensive Patients</brief_title>
  <acronym>WONDeR</acronym>
  <official_title>A Multi-center, Observational, Cross-sectional Study to Evaluate CVD Risk Factors in Korean Hypertensive Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>GlaxoSmithKline</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>GlaxoSmithKline</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is investigating the proportion of Cardiovascular disease risk
      factors of hypertensive patients.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Primary endpoint: To evaluate the Proportion of patients with Cardiovascular disease high
      risk factors

      Secondary endpoint: To evaluate the Proportion of patients with Cardiovascular disease risk
      factors, To evaluate the Proportion of patients with Cardiovascular disease, To evaluate
      Target blood pressure achievement rate according to the proportion of Cardiovascular disease
      risks
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>August 2010</start_date>
  <completion_date type="Actual">January 2011</completion_date>
  <primary_completion_date type="Actual">January 2011</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Proportion of patients with cardiovascular disease high risk factors</measure>
    <time_frame>6years, average duration of hypertension</time_frame>
    <description>Between patients with essential hypertension</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Proportion of patients with Cardiovascular disease risk factors</measure>
    <time_frame>6years, average duration of hypertension</time_frame>
    <description>Between patients with essential hypertension</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Proportion of patients with Cardiovascular disease</measure>
    <time_frame>6years, average duration of hypertension</time_frame>
    <description>Between patients with essential hypertension</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Target Blood Pressure achievement rate according to the proportion of Cardiovascular disease risks</measure>
    <time_frame>6years, average duration of hypertension</time_frame>
    <description>Between patients with essential hypertension</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">3109</enrollment>
  <condition>Hypertension</condition>
  <arm_group>
    <arm_group_label>Hypertension</arm_group_label>
    <description>Subject who meet eligible criteria</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Blood Sampling</intervention_name>
    <description>Blood sampling for Fasting Plasma Glucose, Hemoglobin A1C, Cholesterols, Blood Urea Nitrogen, Creatinine</description>
    <arm_group_label>Hypertension</arm_group_label>
    <other_name>Blood sampling for cardiovascular disease risk</other_name>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Korea, Diagnosed hypertensive patient
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Essential hypertensive patient no less than 18 yeas old

          -  Patient who gave informed consent form

        Exclusion Criteria:

          -  Patient was diagnosed as secondary hypertension

          -  Patient who have white-coat hypertension
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>GSK Clinical Trials</last_name>
    <role>Study Director</role>
    <affiliation>GlaxoSmithKline</affiliation>
  </overall_official>
  <verification_date>November 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 5, 2011</study_first_submitted>
  <study_first_submitted_qc>May 26, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 30, 2011</study_first_posted>
  <last_update_submitted>November 30, 2016</last_update_submitted>
  <last_update_submitted_qc>November 30, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 1, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

